Company / CIK 0001080014
Innoviva, Inc.
- Ticker
- INVA
- Size, estimated from filings
- Small cap ($300M – $2B)
- Insiders on file
- 6
- Federal contracts on record
- none matched
- Lobbying filings on record
- none matched
- SEC filings
- EDGAR ↗
- Latest trade on record
- August 20, 2026
Innoviva, Inc. (INVA) has 6 insiders on file who disclosed 17 transactions in the last 12 months (0 open-market buys, 6 sales, about $122K at reported prices). No federal contract award that started in the last 180 days was found for a recipient with exactly this name; no lobbying filing names it as client this year.
Innoviva, Inc. in charts
Who is trading this stock
Which people account for the buying and selling over the last 12 months?
3 people account for the disclosed buying and selling in Innoviva, Inc. over the last 12 months; the most active is Raifeld Pavel with $49K.
Insiders
| Name | Role | Rows | Bought | Sold | Last filed |
|---|---|---|---|---|---|
| Zhen Marianne | Chief Accounting Officer | 4 | 0 | 2 | August 24, 2026 |
| Basso Stephen | Chief Financial Officer | 3 | 0 | 2 | August 24, 2026 |
| Raifeld Pavel | Chief Executive Officer | 5 | 0 | 2 | August 24, 2026 |
| Linden Josephine | Director | 3 | 0 | 0 | May 20, 2026 |
| DiPaolo Mark | Director | 2 | 0 | 0 | May 6, 2026 |
| GLAXOSMITHKLINE PLC | Insider | 1 | 0 | 1 | December 15, 2025 |
Rows are this company's Form 4 rows for each person. "Bought" and "sold" count open-market purchases (code P) and sales only. More in insider buying and insider selling.
Insider transactions
| Filer | Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Raifeld Pavel | INVA | Sell F | August 20, 2026 | August 24, 2026 | 4d | 1,130 | $21 | $24K | Form 4 ↗ | ||
| Basso Stephen | INVA | Sell F | August 20, 2026 | August 24, 2026 | 4d | 558 | $21 | $12K | Form 4 ↗ | ||
| Zhen Marianne | INVA | Sell F | August 20, 2026 | August 24, 2026 | 4d | 1,127 | $21 | $24K | Form 4 ↗ | ||
| Zhen Marianne | INVA | Sell F | May 20, 2026 | May 22, 2026 | 2d | 1,127 | $22 | $25K | Form 4 ↗ | ||
| Raifeld Pavel | INVA | Sell F | May 20, 2026 | May 22, 2026 | 2d | 1,130 | $22 | $25K | Form 4 ↗ | ||
| Raifeld Pavel | INVA | Other A | May 15, 2026 | May 22, 2026 | 7d | 1,123 | — | — | late | Form 4 ↗ | |
| Basso Stephen | INVA | Sell F | May 20, 2026 | May 22, 2026 | 2d | 559 | $22 | $12K | Form 4 ↗ | ||
| Basso Stephen | INVA | Other A | May 15, 2026 | May 22, 2026 | 7d | 1,123 | — | — | late | Form 4 ↗ | |
| Linden Josephine | INVA | Other A | May 18, 2026 | May 20, 2026 | 2d | 9,166 | — | — | derivative | Form 4 ↗ | |
| Linden Josephine | INVA | Other A | May 18, 2026 | May 20, 2026 | 2d | 9,461 | — | — | Form 4 ↗ | ||
| Linden Josephine | INVA | Other A | May 18, 2026 | May 20, 2026 | 2d | 5,733 | — | — | Form 4 ↗ | ||
| Zhen Marianne | INVA | Other A | May 4, 2026 | May 6, 2026 | 2d | 31,500 | — | — | derivative | Form 4 ↗ | |
| Zhen Marianne | INVA | Other A | May 4, 2026 | May 6, 2026 | 2d | 12,766 | — | — | Form 4 ↗ | ||
| Raifeld Pavel | INVA | Other A | May 4, 2026 | May 6, 2026 | 2d | 312,500 | — | — | derivative | Form 4 ↗ | |
| Raifeld Pavel | INVA | Other A | May 4, 2026 | May 6, 2026 | 2d | 126,646 | — | — | Form 4 ↗ | ||
| DiPaolo Mark | INVA | Other A | May 4, 2026 | May 6, 2026 | 2d | 10,000 | — | — | derivative | Form 4 ↗ | |
| DiPaolo Mark | INVA | Other A | May 4, 2026 | May 6, 2026 | 2d | 9,786 | — | — | Form 4 ↗ | ||
| GLAXOSMITHKLINE PLC | INVA | Sell S | May 20, 2021 | May 24, 2021 | 4d | 32,005,260 | $12 | $392.1M | indirect | Form 4 ↗ |
Federal contracts (USAspending, awards started in the last 180 days)
No contract award starting in the last 180 days was found for a recipient named exactly "Innoviva, Inc.". Subsidiaries and differently-spelled recipients are not matched — search contracts.
Lobbying (Senate LDA, as client)
No LDA filing posted since October 2025 names "Innoviva, Inc." as the client. Filings under a subsidiary or trade-association name are not matched — search lobbying.
Related companies
Companies whose stock was traded by the same people who traded INVA, by number of filers in common. It shows overlap in public filings and nothing else.
- Wave Life Sciences, Inc. WVE 1 filer in common
- BICYCLE THERAPEUTICS PLC BCYC 1 filer in common
- CVRx, Inc. CVRX 1 filer in common
- Lyell Immunopharma, Inc. LYEL 1 filer in common
- Decibel Therapeutics, Inc. DBTX 1 filer in common
- GENOCEA BIOSCIENCES, INC. GNCA 1 filer in common
- Theravance Biopharma, Inc. TBPH 1 filer in common
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 11 | 18 | May 24, 2021 | August 24, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insiders and their transactions come from SEC EDGAR Form 4 filings for this issuer. Contracts and lobbying are matched by exact normalized name (suffixes like Inc./Corp. ignored) to USAspending recipients and LDA clients — a conservative match that misses subsidiaries on purpose. See methodology and corrections.
Not investment advice. Public records shown as filed; no recommendation is made or implied.